Filtros de búsqueda

Lista de obras de Rieke Alten

A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria

artículo científico

Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries

artículo científico publicado en 2019

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.

artículo científico publicado en 2018

Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group

scientific article published on 15 February 2019

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment.

artículo científico publicado en 2018

Correction to: Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017

artículo científico publicado en 2020

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 02 June 2020

Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status

scientific article published on 01 December 2018

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

artículo científico publicado en 2015

Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis

artículo científico publicado en 2020

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

artículo científico publicado en 2014

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

artículo científico publicado en 2015

Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis

artículo científico publicado en 2020

Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools

artículo científico publicado en 2016

Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis

scientific article published on 12 January 2019

Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis

artículo científico publicado en 2019

Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies

scientific article published on 01 April 2020

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions

artículo científico publicado en 2019

OMERACT endorsement of measures of outcome for studies of acute gout

artículo científico publicado en 2013

Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017

scientific article published on 06 May 2020

Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol

artículo científico publicado en 2018

Physical and Emotional Burden of Rheumatoid Arthritis in Saudi Arabia: An Exploratory Cross-Sectional Study

artículo científico publicado en 2020

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.

artículo científico publicado en 2015

Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study

scientific article published on 21 February 2019

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54

artículo científico publicado en 2019

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.

artículo científico publicado en 2015

Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study

artículo científico publicado en 2020

Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients

artículo científico publicado en 2021

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 01 February 2020

Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial

artículo científico publicado en 2016

Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda